| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$102 |
Update - Notification of buy-back - CAM
|
12 Jan 2026 8:39AM |
$0.700 |
$0.710 |
risen by
1.43%
|
|
| RocketDNA Ltd (RKT) ORDINARY FULLY PAID |
Information Technology |
$31 |
Vesting of 2025 Performance Rights
|
12 Jan 2026 8:39AM |
$0.030 |
$0.026 |
fallen by
13.33%
|
|
| Larvotto Resources Limited (LRV) ORDINARY FULLY PAID |
Materials |
$736 |
Drilling at Metz Continues to Deliver
|
12 Jan 2026 8:35AM |
$1.190 |
$1.420 |
risen by
19.33%
|
|
LRV - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling at the Blacklode Prospect reveals significant antimony and gold mineralisation.
- Near surface high-grade mineralisation extends the western extension of the Metz system.
- Key intercepts include BLK106: 6m @ 8.50g/t AuEq from 92m and BLK107: 16m @ 5.43g/t AuEq from 294m.
- Significant tungsten mineralisation associated with antimony-gold lodes intersected.
- The Metz system shows extensive exploration potential despite its long history.
- Larvotto Resources aims to expand resource base and identify new mineralised splays.
- The exploration programs are part of a strategy to deliver additional mineable material to the Metz Mining Centre.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Partners Limited (RPL) ORDINARY FULLY PAID |
Financials |
$1,101 |
2025 NPAT guidance of $145m, performance fee upgrade
|
12 Jan 2026 8:35AM |
$3.400 |
$2.980 |
fallen by
12.35%
|
|
RPL - Price-sensitive ASX Announcement
Full Release
Key Points
- 2025 NPAT guidance of $145 million driven by performance fee upgrade.
- Funds under management rose to $20.8 billion as of December 2025.
- Net inflows for the December quarter were approximately $80 million.
- Total net inflows for 2025 reached $1.5 billion.
- Preliminary unaudited estimates subject to finalization and review.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$418 |
Update - Notification of buy-back - RG8
|
12 Jan 2026 8:33AM |
$2.750 |
$2.880 |
risen by
4.73%
|
|
| Litchfield Minerals Limited (LMS) ORDINARY FULLY PAID |
Materials |
$30 |
EM Defines 3000-Siemens Conductor & 1km Carbonate Unit - VT1
|
12 Jan 2026 8:33AM |
$0.480 |
$0.525 |
risen by
9.38%
|
|
LMS - Price-sensitive ASX Announcement
Full Release
Key Points
- Ground EM at VT1 defined six conductor plates with high conductance.
- A 1km carbonate unit was identified, indicating a potential new mineral zone.
- VT2 surveys validated existing data and discovered new chargeability anomalies.
- Exploration in 2026 will focus on deepening investigations with advanced geophysical techniques.
- Targeted drilling will aim to expand the near-surface resource base and explore deeper targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Firebrick Pharma Limited (FRE) ORDINARY FULLY PAID |
Health Care |
$15 |
Update on Registration of Nasodine in the Philippines
|
12 Jan 2026 8:32AM |
$0.066 |
$0.058 |
fallen by
12.12%
|
|
| EBR Systems Inc (EBR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$311 |
EBR to Present at 44th Annual JP Morgan Health Conference
|
12 Jan 2026 8:32AM |
$0.985 |
$0.690 |
fallen by
29.95%
|
|
| Stockland (SGP) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$11,818 |
Notification of cessation of securities - SGP
|
12 Jan 2026 8:31AM |
$5.530 |
$4.860 |
fallen by
12.12%
|
|
| EBR Systems Inc (EBR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$311 |
Strong Q4 FY2025 Commercial and Clinical Progress
|
12 Jan 2026 8:30AM |
$0.985 |
$0.690 |
fallen by
29.95%
|
|
EBR - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong commercial momentum in Q4 2025.
- Doubling of case volumes with WiSE System implants.
- Expected revenue range for Q4 2025 is US$870K to US$935K.
- Total revenue for 2025 projected to be US$1,552K to US$1,617K.
- Commencement of the WiSE-UP post-approval study.
- Initiation of the TLC-AU feasibility study.
- 9 additional purchase agreements signed.
- 11 new physicians trained for WiSE System implantation.
- Active investor engagement and participation in conferences.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stockland (SGP) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$11,818 |
Notification regarding unquoted securities - SGP
|
12 Jan 2026 8:30AM |
$5.530 |
$4.860 |
fallen by
12.12%
|
|
| Regal Partners Global Investments Limited (RG1) ORDINARY FULLY PAID |
Financials |
$542 |
Update - Notification of buy-back - RG1
|
12 Jan 2026 8:29AM |
$2.310 |
$2.250 |
fallen by
2.60%
|
|
| Cyclopharm Limited (CYC) ORDINARY FULLY PAID |
Health Care |
$93 |
Stanford Children's Health to Implement Technegas
|
12 Jan 2026 8:28AM |
$0.940 |
$0.770 |
fallen by
18.09%
|
|
CYC - Price-sensitive ASX Announcement
Full Release
Key Points
- Cyclopharm Limited partners with Stanford Medicine Children’s Health.
- Lucile Packard Children’s Hospital Stanford to implement Technegas.
- First U.S. children's hospital to adopt Technegas.
- Technegas offers low radiation dose, ideal for pediatric use.
- Cyclopharm expanding U.S. installations for broader access.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ansell Limited (ANN) ORDINARY FULLY PAID |
Health Care |
$4,398 |
Notice of FY26 Half Year Results Announcement
|
12 Jan 2026 8:28AM |
$33.490 |
$30.575 |
fallen by
8.70%
|
|
| Ophir High Conviction Fund (OPH) ORDINARY UNITS FULLY PAID |
Financials |
$621 |
Weekly NTA 09.01.2026
|
12 Jan 2026 8:28AM |
$3.260 |
$2.790 |
fallen by
14.42%
|
|
| RAM Essential Services Property Fund (REP) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$268 |
Dividend Details
|
12 Jan 2026 8:28AM |
$0.573 |
$0.535 |
fallen by
6.55%
|
|
| Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$645 |
FDA Clears VISION-MR Diagnostic Catheter
|
12 Jan 2026 8:28AM |
$1.580 |
$2.010 |
risen by
27.22%
|
|
IMR - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA grants 510(k) clearance for Vision-MR Diagnostic Catheter.
- First FDA clearance for Imricor Medical Systems Inc.
- Catheter designed for use with real-time MRI guidance.
- Part of Imricor’s MRI-compatible electrophysiology device platform.
- Clearance allows marketing in the US, the largest electrophysiology market.
- Steve Wedan highlights milestone and team effort.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bravura Solutions Limited (BVS) ORDINARY FULLY PAID |
Information Technology |
$957 |
Notification regarding unquoted securities - BVS
|
12 Jan 2026 8:28AM |
$2.560 |
$2.135 |
fallen by
16.60%
|
|
| Bravura Solutions Limited (BVS) ORDINARY FULLY PAID |
Information Technology |
$957 |
Notification of cessation of securities - BVS
|
12 Jan 2026 8:28AM |
$2.560 |
$2.135 |
fallen by
16.60%
|
|
| Bravura Solutions Limited (BVS) ORDINARY FULLY PAID |
Information Technology |
$957 |
Notification regarding unquoted securities - BVS
|
12 Jan 2026 8:28AM |
$2.560 |
$2.135 |
fallen by
16.60%
|
|
| Dimerix Limited (DXB) ORDINARY FULLY PAID |
Health Care |
$243 |
Clinical trial update at J.P. Morgan Healthcare Conference
|
12 Jan 2026 8:28AM |
$0.540 |
$0.405 |
fallen by
25%
|
|
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$449 |
Further Resource Definition Drilling Results at Iguana
|
12 Jan 2026 8:27AM |
$3.400 |
$4.030 |
risen by
18.53%
|
|
BCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Beacon has received assay results for a further 104 RC holes totalling 14,787 metres.
- High grade gold mineralization identified at various depths.
- Significant mineralisation zones with high continuity and super high-grade zones.
- Results will contribute to a Resource and Reserves update planned for the financial year end.
- The Iguana Deposit is part of the Lady Ida Project located on the Mount Ida Greenstone Belt.
- The mineralisation is structurally and hydrothermally controlled.
- The deposit exhibits two distinct mineralisation styles: early stage sulphide-rich and later stage quartz-fuchsite.
- Drilling results indicate strong grade continuity at depth.
- Mineral tenement consists of M16/262 and other associated areas under agreement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Naos Emerging Opportunities Company Limited (NCC) ORDINARY FULLY PAID |
Financials |
$33 |
NTA & Portfolio Update - December 2025
|
12 Jan 2026 8:27AM |
$0.440 |
$0.445 |
risen by
1.14%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,779 |
Net Tangible Asset Backing
|
12 Jan 2026 8:27AM |
$4.140 |
$4.390 |
risen by
6.04%
|
|
| NAOS Ex-50 Opportunities Company Limited (NAC) ORDINARY FULLY PAID |
Financials |
$31 |
NTA & Portfolio Update - December 2025
|
12 Jan 2026 8:27AM |
$0.700 |
$0.670 |
fallen by
4.29%
|
|